VTGN: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-34,512	-15,095
Depreciation and amortization	93	40
Stock-based compensation	2,012	916
Amortization of operating lease right-of-use asset	261	129
Non-cash interest expense	2	3
Accretion on marketable securities	-270	-125
Prepaid expenses and other current assets	165	1,942
Other assets	37	37
Operating lease liability	-302	-86
Deferred revenue, net of deferred contract acquisition costs	-464	-225
Accounts payable and accrued expenses	777	-2,424
Net cash used in operating activities	-32,605	-18,846
Purchases of laboratory and other equipment	125	65
Sales and maturities of marketable securities	10,000	8,000
Purchases of marketable securities	10,757	8,723
Net cash used in investing activities	-882	-788
Net proceeds from sale of common stock under open market sale agreement, net of offering costs	28,325	397
Net proceeds from sale of common stock under 2019 employee stock purchase plan	161	161
Issuance of note payable for insurance policy	1,020	1,020
Repayment of notes payable	364	90
Net cash provided by financing activities	29,142	1,488
Net change in cash and cash equivalents	-4,345	-18,146
Cash and cash equivalents at beginning of period	67,131	-
Cash and cash equivalents at end of period	62,786	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

VTGN: the cashflow